BIOMARIN PHARMACEUTICAL INC Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of $2.07 million for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-08.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2016-08-08
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2016-06-30 was $2.07M.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2016-03-31 was -$16.16M, a 163.98% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-06-30 was -$5.16M.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-03-31 was $25.25M.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before reclassifications, net of tax for fiscal 2015 was $14.36M, a 37.80% decline from fiscal 2014.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before reclassifications, net of tax for fiscal 2014 was $23.09M, a 338.16% increase from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), before reclassifications, net of tax for fiscal 2013 was $5.27M.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|---|
| 2016-06-30 | $2.07M 10-Q · filed 2016-08-08 | -$14.09M 10-Q · filed 2016-08-08 | ||
| 2016-03-31 | -$16.16M 10-Q · filed 2016-05-02 | |||
| 2015-12-31 | $14.36M 10-K · filed 2016-02-29 | |||
| 2015-06-30 | -$5.16M 10-Q · filed 2016-08-08 | $20.09M 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $25.25M 10-Q · filed 2016-05-02 | |||
| 2014-12-31 | $23.09M 10-K · filed 2016-02-29 | |||
| 2013-12-31 | -$7.02M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $2.07M derived: sum of 2 quarters · filed 2014-02-26 | $5.27M 10-K · filed 2014-02-26 | |
| 2013-09-30 | $9.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $12.29M 10-Q · filed 2013-10-28 | ||
| 2013-06-30 | $3.20M 10-Q · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |